Could tissue sparing surgery get rid of that pain in the neck?
The Fuse Trial is a prospective, randomized, controlled study, which means participants will be randomly chosen to receive ACDF alone or ACDF plus supplemental stabilization with posterior cervical stabilization system (PCSS). The trial will determine if ACDF plus PCSS will result in superior clinical outcomes versus ACDF alone in the treatment of 3-level cervical degenerative disease.
“The goal of this study is to find the most effective method for positive outcomes in high-risk patients, specifically for ACDFs spanning three levels,” Xu said. “We want to help create the gold standard for this type of surgery, making it easier for patients to recover with minimal damage to the muscles in the neck.”
The study is seeking to enroll 330 patients. Participants should be between 18 to 80 years of age and have been recommended for ACDF treatment for degenerative disc disease between and including the C3-C7 vertebrae. The study is sponsored by Providence Medical Technology.
For a full list of study locations and eligibility criteria, see clinicaltrials.gov.